| EU okays Astra, BMS diabetes drug for kidney cases - Reuters |
|
|
Reuters N) established diabetes drug Onglyza has been approved in Europe for treating people with type 2 diabetes who have moderate or severe renal impairment. The green light from the European Commission for the extended use makes Onglyza the first so-called ... EC Approves BMS and AstraZeneca's Type 2 Diabetes Therapy for Renally Impaired |